March 01, 2023 — 08:40 am EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - Eli Lilly and Company (LLY) announced price reductions of 70% for its most commonly prescribed insulins. Also, effective immediately, Lilly will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin.
The company stated that people who don't have insurance can continue to go to InsulinAffordability.com and immediately download the Lilly Insulin Value Program savings card to receive Lilly insulins for $35 per month.
Eli Lilly is also launching Rezvoglar injection, a basal insulin that is biosimilar to, and interchangeable with, Lantus injection, for $92 per five pack of KwikPens, a 78% discount to Lantus, effective April 1, 2023.
For More Such Health News, visit rttnews.com. 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.